Curcumin inhibits oral squamous cell carcinoma SCC-9 cells proliferation by regulating miR-9 expression

Biochemical and Biophysical Research Communications

Volumn 454, Issue 4, 2014, Pages 576-580

  Xiao, Can ^a,b   Wang, Lili ^b   Zhu, Lifang ^b   Zhang, Chenping ^c   Zhou, Jianhua ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Curcumin miR 9 Wnt catenin signaling; Oral squamous cell carcinoma

Indexed keywords

BETA CATENIN; CURCUMIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MICRORNA 9; OLIGONUCLEOTIDE; WNT PROTEIN; ANTINEOPLASTIC AGENT; MICRORNA; MIRN92 MICRORNA, HUMAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; CARCINOMA, SQUAMOUS CELL; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; GENETICS; METABOLISM; MOUTH NEOPLASMS; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICRORNAS; MOUTH NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84910654976     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.10.122     Document Type: Article

References (29)

1. W. Meng, Y. Wu, and X. He A systems biology approach identifies effective tumor-stroma common targets for oral squamous cell carcinoma Cancer Res. 74 2014 2306 2315
2. F. Xavier, M. Destro, and C. Duarte Epigenetic repression of HOXB cluster in oral cancer cell lines Arch. Oral Biol. 59 2014 783 789
3. H. Zhang, X. Nan, and X. Li CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma Biochem. Biophys. Res. Commun. 447 2014 304 310
4. J. Bezerra, and A. Latronico MicroRNA Era: the importance for diagnosis and prognosis of adrenocortical tumors Biomed Res. Int. 2014 2014 381917
5. J. Wu, Y. Yao, and T. Gu MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3 Asian Pac. J. Cancer Prev. 15 2014 5463 5468
6. Y. Lang, S. Xu, and J. Ma MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes Biochem. Biophys. Res. Commun. 450 2014 154 159
7. F. Gao, Z. Zhao, and W. Zhao MiR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells Biochem. Biophys. Res. Commun. 431 2013 610 616
8. L. Cekaite, J. Rantala, and J. Bruun MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer Neoplasia 14 2012 868 879
9. S. Selcuklu, M. Donoghue, and K. Rehmet MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells J. Biol. Chem. 287 2012 29516 29528
10. Z. Sun, Q. Han, and N. Zhou MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma Mol. Oncol. 7 2013 884 894
11. L. Zhu, H. Chen, and D. Zhou MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility Med. Oncol. 29 2012 1037 1043
12. C. Xiao, L. Wang, and L. Zhu Secreted frizzled-related protein 2 is epigenetically silenced and functions as a tumor suppressor in oral squamous cell carcinoma Mol. Med. Rep. 2014 (Epub ahead of print)
13. Y. Li, and T. Zhang Targeting cancer stem cells by curcumin and clinical applications Cancer Lett. 346 2014 197 205
14. C. Prasad, G. Rath, and S. Mathur Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling Chem. Biol. Interact. 181 2009 263 271
15. S. Zhao, X. Zhang, and X. Zhang Induction of microRNA-9 mediates cytotoxicity of curcumin against SKOV3 ovarian cancer cells Asian Pac. J. Cancer Prev. 15 2014 3363 3368
16. Y. Guo, Q. Shan, and Y. Gong Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells Pharmazie 69 2014 229 233
17. R. VanderBroek, G. Snow, and Z. Chen Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling Oral. Oncol. 50 2013 930 941
18. O. Yang, J. Huang, and S. Lin Regulatory effects of miRNA on gastric cancer cells Oncol. Lett. 8 2014 651 656
19. J. Lu, H. Luo, and X. Liu MiR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma Carcinogenesis 35 2014 554 563
20. Y. Ma, G. Zhang, and X. Fu Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression Oncol. Rep. 23 2010 1569 1576
21. P. Jabbarzadeh Kaboli, A. Rahmat, and P. Ismail Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer Eur. J. Pharmacol. 740 2014 584 595
22. R. Morgan, J. Ridsdale, and A. Tonks Factors affecting the nuclear localization of β-catenin in normal and malignant tissue J. Cell. Biochem. 115 2014 1351 1361
23. M. Jalving, D. Heijink, and J. Koornstra Regulation of TRAIL receptor expression by β-catenin in colorectal tumours Carcinogenesis 35 2014 1092 1099
24. B. Moon, W. Jeong, and J. Park Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling J. Natl. Cancer Inst. 106 2014 (djt373)
25. R. Tarapore, I. Siddiqui, and V. Adhami The dietary terpene lupeol targets colorectal cancer cells with constitutively active Wnt/β-catenin signaling Mol. Nutr. Food Res. 57 2013 1950 1958
26. T. Saito, H. Mitomi, and A. Imamhasan Ownregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma Virchows Arch. 464 2014 135 143
27. M. Takeda, T. Nagasaka, and S. Dong-Sheng Expansion of CpG methylation in the SFRP2 promoter region during colorectal tumorigenesis Acta Med. Okayama 65 2011 169 177
28. A. Gupta, A. Verma, and A.K. Mishra The Wnt pathway: emerging anticancer strategies Recent Pat. Endocr. Metab. Immune Drug Discov. 7 2013 138 147
29. L. Wang, S. Chen, and S. Zhuang Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathway Pathol. Oncol. Res. 19 2013 461 474